| Autor: |
Buti M; Liver Unit, Hospital Universitario Valle Hebron and CIBER-EHD del Instituto Carlos III, Barcelona, Spain., Duffell E; European Centre for Disease Prevention and Control, Stockholm, Sweden. |
| Jazyk: |
angličtina |
| Zdroj: |
Clinical liver disease [Clin Liver Dis (Hoboken)] 2024 Jun 28; Vol. 23 (1), pp. e0229. Date of Electronic Publication: 2024 Jun 28 (Print Publication: 2024). |
| DOI: |
10.1097/CLD.0000000000000229 |
| Abstrakt: |
Competing Interests: Maria Buti advises Gilead, GSK and Janssen. The remaining author has no conflicts to report. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
